Published in Int J Cardiol on July 23, 2011
How to manage coronary slow flow following PCI? Int J Cardiol (2011) 1.39
Iron-induced fibrin in cardiovascular disease. Curr Neurovasc Res (2013) 0.83
Admission glucose, fasting glucose, HbA1c levels and the SYNTAX score in non-diabetic patients undergoing coronary angiography. Clin Res Cardiol (2013) 0.77
Influence of red blood cell aggregation on perfusion of an artificial microvascular network. Microcirculation (2016) 0.76
Efficacy of a device to narrow the coronary sinus in refractory angina. N Engl J Med (2015) 5.36
Mandatory electrocardiographic screening of athletes to reduce their risk for sudden death proven fact or wishful thinking? J Am Coll Cardiol (2011) 3.86
Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. J Am Coll Cardiol (2004) 3.67
Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes. Eur Heart J (2006) 2.93
J-point elevation in survivors of primary ventricular fibrillation and matched control subjects: incidence and clinical significance. J Am Coll Cardiol (2008) 2.87
Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography. Atherosclerosis (2012) 2.38
Fever-induced Brugada pattern: how common is it and what does it mean? Heart Rhythm (2013) 2.25
Circulating endothelial progenitor cells in patients with unstable angina: association with systemic inflammation. Eur Heart J (2004) 2.14
What do we know about the "malignant form" of early repolarization? J Am Coll Cardiol (2013) 2.11
Transcatheter treatment for refractory angina with the Coronary Sinus Reducer. EuroIntervention (2014) 2.07
Burnout and risk of cardiovascular disease: evidence, possible causal paths, and promising research directions. Psychol Bull (2006) 2.01
Distinguishing "benign" from "malignant early repolarization": the value of the ST-segment morphology. Heart Rhythm (2011) 1.90
Circulating matrix metalloproteinase-2 but not matrix metalloproteinase-3, matrix metalloproteinase-9, or tissue inhibitor of metalloproteinase-1 predicts outcome in patients with congestive heart failure. Am Heart J (2005) 1.88
The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells. Atherosclerosis (2007) 1.87
Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis. Arterioscler Thromb Vasc Biol (2007) 1.79
Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors. Medicine (Baltimore) (2003) 1.78
Hypoxia controls CD4+CD25+ regulatory T-cell homeostasis via hypoxia-inducible factor-1alpha. Eur J Immunol (2008) 1.69
Relation of educational level to inflammation-sensitive biomarker level. Am J Cardiol (2008) 1.64
Realizing the potential of carotid artery stenting: proposed paradigms for patient selection and procedural technique. Circulation (2006) 1.64
Predictive value of high sensitivity CRP in patients with diastolic heart failure. Int J Cardiol (2007) 1.63
Diagnostic yield of extensive infectious panel testing in acute pericarditis. Cardiology (2011) 1.55
Erythropoietin improves myocardial performance in doxorubicin-induced cardiomyopathy. Eur Heart J (2006) 1.52
Impact of estimated glomerular filtration rate on vascular disease extent and adverse cardiovascular events in patients without chronic kidney disease. Can J Cardiol (2013) 1.52
Inflammatory bowel disease is not associated with increased intimal media thickening. Am J Gastroenterol (2007) 1.50
Isolated ventricular non-compaction: an underdiagnosed cause of congestive heart failure. Isr Med Assoc J (2009) 1.49
Cardiovascular risk factors in men with ischemic heart disease and erectile dysfunction. Urology (2013) 1.47
Islet-1 gene delivery improves myocardial performance after experimental infarction. Atherosclerosis (2012) 1.43
Coronary sinus reducer stent for the treatment of chronic refractory angina pectoris: a prospective, open-label, multicenter, safety feasibility first-in-man study. J Am Coll Cardiol (2007) 1.40
Risk of sudden death among young individuals with J waves and early repolarization: putting the evidence into perspective. Heart Rhythm (2011) 1.40
Predictors of high-risk angiographic findings in patients with non-ST-segment elevation acute coronary syndrome. Catheter Cardiovasc Interv (2013) 1.39
Percutaneous implantation of the self-expandable CoreValve for high risk patients with severe aortic valve stenosis: early Israeli experience. Isr Med Assoc J (2010) 1.39
Treatment of severe valvular aortic stenosis and subvalvular discrete subaortic stenosis and septal hypertrophy with Percutaneous CoreValve Aortic Valve Implantation. Catheter Cardiovasc Interv (2010) 1.39
Blood banking-induced alteration of red blood cell flow properties. Transfusion (2007) 1.36
The association between burnout, depression, anxiety, and inflammation biomarkers: C-reactive protein and fibrinogen in men and women. J Occup Health Psychol (2005) 1.31
Comparative analysis of methods for assessment of circulating endothelial progenitor cells. Tissue Eng (2006) 1.29
Drug-induced atrioventricular block: prognosis after discontinuation of the culprit drug. J Am Coll Cardiol (2004) 1.28
Long QT syndrome caused by noncardiac drugs. Prog Cardiovasc Dis (2003) 1.22
Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. J Am Coll Cardiol (2004) 1.21
Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol (2005) 1.21
The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron. Nephrol Dial Transplant (2003) 1.18
The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosis. J Am Coll Cardiol (2005) 1.17
Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis. Semin Arthritis Rheum (2006) 1.17
Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis. Arterioscler Thromb Vasc Biol (2003) 1.16
Circulating endothelial progenitor cells in patients with cardiac syndrome X. Heart (2006) 1.11
Short-term exposure to air pollution and inflammation-sensitive biomarkers. Environ Res (2007) 1.11
Platelet counts and platelet activation markers in obese subjects. Mediators Inflamm (2008) 1.10
Transcatheter aortic valve implantation: a single-center experience of 300 cases. Isr Med Assoc J (2013) 1.09
Extracellular phospholipase A2 inhibitors suppress central nervous system inflammation. Glia (2003) 1.05
Serum cholinesterase activities distinguish between stroke patients and controls and predict 12-month mortality. Mol Med (2010) 1.04
Prevalence and predictors of concomitant carotid and coronary artery atherosclerotic disease. J Am Coll Cardiol (2011) 1.03
Platelet inhibitory effect of clopidogrel in patients treated with omeprazole, pantoprazole, and famotidine: a prospective, randomized, crossover study. Clin Cardiol (2013) 1.02
Tiara: a novel catheter-based mitral valve bioprosthesis: initial experiments and short-term pre-clinical results. J Am Coll Cardiol (2012) 1.02
Environmental air pollution has decremental effects on pulmonary function test parameters up to one week after exposure. Am J Med Sci (2009) 1.01
Circulating endothelial progenitor cells and clinical outcome in patients with congestive heart failure. Heart (2007) 0.99
Burnout and risk of coronary heart disease: a prospective study of 8838 employees. Psychosom Med (2012) 0.97
Primary angioplasty with routine stenting compared with thrombolytic therapy in elderly patients with acute myocardial infarction. Am Heart J (2003) 0.97
MicroRNA-132 modulates cholinergic signaling and inflammation in human inflammatory bowel disease. Inflamm Bowel Dis (2013) 0.97
Circulating apoptotic progenitor cells in patients with congestive heart failure. PLoS One (2008) 0.97
Interleukin-33 augments Treg cell levels: a flaw mechanism in atherosclerosis. Isr Med Assoc J (2012) 0.96
Trajectories of posttraumatic stress disorder following myocardial infarction: a prospective study. J Clin Psychiatry (2003) 0.96
Treatment of post-catheterization femoral artery pseudo-aneurysm with para-aneurysmal saline injection. Am J Cardiol (2008) 0.95
Hypereosinophilic syndrome with cardiac involvement: early diagnosis by cardiac magnetic resonance imaging. Can J Cardiol (2012) 0.95
Thrombophilic factors in idiopathic intracranial hypertension: a report of 51 patients and a meta-analysis. Blood Coagul Fibrinolysis (2010) 0.95
Erythropoietin promotes endothelial progenitor cell proliferative and adhesive properties in a PI 3-kinase-dependent manner. Cardiovasc Res (2005) 0.94
Anaemia as a contributor to morbidity and mortality in congestive heart failure. Nephrol Dial Transplant (2005) 0.94
Constitutive expression of HIF-1alpha and HIF-2alpha in bone marrow stromal cells differentially promotes their proangiogenic properties. Stem Cells (2008) 0.93